TerminatedPhase 3

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

NCT00089141

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

City of Hope Comprehensive Cancer Center

Duarte, California, United States

+15 additional locations

Save this trial

City of Hope Comprehensive Cancer CenterDuarte, California, United States
Stanford Cancer CenterStanford, California, United States
University of Florida Shands Cancer CenterGainesville, Florida, United States
University of Chicago Cancer Research CenterChicago, Illinois, United States
University of Michigan Comprehensive Cancer CenterAnn Arbor, Michigan, United States
Masonic Cancer Center at University of MinnesotaMinneapolis, Minnesota, United States
UNMC Eppley Cancer Center at the University of Nebraska Medical CenterOmaha, Nebraska, United States
Hackensack University Medical Center Cancer CenterHackensack, New Jersey, United States
Oregon Health and Science University Cancer InstitutePortland, Oregon, United States
Vanderbilt-Ingram Cancer CenterNashville, Tennessee, United States
Baylor University Medical Center - DallasDallas, Texas, United States
M. D. Anderson Cancer Center at University of TexasHouston, Texas, United States
Texas Transplant InstituteSan Antonio, Texas, United States
Fred Hutchinson Cancer Research CenterSeattle, Washington, United States
University of Washington School of MedicineSeattle, Washington, United States
Princess Margaret HospitalToronto, Ontario, Canada